299 related articles for article (PubMed ID: 15681305)
1. Apolipoprotein E and atherosclerosis: beyond lipid effect.
Davignon J
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):267-9. PubMed ID: 15681305
[No Abstract] [Full Text] [Related]
2. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.
Meir KS; Leitersdorf E
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1006-14. PubMed ID: 15087308
[TBL] [Abstract][Full Text] [Related]
4. Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice.
Persson L; Borén J; Robertson AK; Wallenius V; Hansson GK; Pekna M
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1062-7. PubMed ID: 15059809
[TBL] [Abstract][Full Text] [Related]
5. Mouse models of experimental atherosclerosis.
Jawień J; Nastałek P; Korbut R
J Physiol Pharmacol; 2004 Sep; 55(3):503-17. PubMed ID: 15381823
[TBL] [Abstract][Full Text] [Related]
6. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice.
Matsui Y; Rittling SR; Okamoto H; Inobe M; Jia N; Shimizu T; Akino M; Sugawara T; Morimoto J; Kimura C; Kon S; Denhardt D; Kitabatake A; Uede T
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1029-34. PubMed ID: 12730087
[TBL] [Abstract][Full Text] [Related]
8. [Hereditary changes of apolipoproteins B and E].
Gaeta G; Effuso L; Maurea N; Boccalatte M; Antignano A; Sifola C; Scala R
Clin Ter; 1994 Jun; 144(6):527-37. PubMed ID: 8001338
[TBL] [Abstract][Full Text] [Related]
9. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice.
Zhang S; Picard MH; Vasile E; Zhu Y; Raffai RL; Weisgraber KH; Krieger M
Circulation; 2005 Jun; 111(25):3457-64. PubMed ID: 15967843
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?
Tabas I
Circulation; 2004 Nov; 110(22):3400-1. PubMed ID: 15569847
[No Abstract] [Full Text] [Related]
11. Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease.
Tabibiazar R; Wagner RA; Spin JM; Ashley EA; Narasimhan B; Rubin EM; Efron B; Tsao PS; Tibshirani R; Quertermous T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):302-8. PubMed ID: 15550693
[TBL] [Abstract][Full Text] [Related]
12. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
Cozen AE; Moriwaki H; Kremen M; DeYoung MB; Dichek HL; Slezicki KI; Young SG; Véniant M; Dichek DA
Circulation; 2004 May; 109(17):2129-35. PubMed ID: 15096455
[TBL] [Abstract][Full Text] [Related]
14. The child is father of the man.
Glueck CJ
Pediatrics; 1986 Aug; 78(2):364-8. PubMed ID: 3526271
[No Abstract] [Full Text] [Related]
15. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
16. Loss of lysophospholipase 3 increases atherosclerosis in apolipoprotein E-deficient mice.
Taniyama Y; Fuse H; Satomi T; Tozawa R; Yasuhara Y; Shimakawa K; Shibata S; Hattori M; Nakata M; Taketomi S
Biochem Biophys Res Commun; 2005 Apr; 330(1):104-10. PubMed ID: 15781238
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
18. Unexpected proatherogenic properties of p21: beyond cell cycle control?
Andrés V
Circulation; 2004 Dec; 110(25):3749-52. PubMed ID: 15611388
[No Abstract] [Full Text] [Related]
19. Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
Wang SS; Shi W; Wang X; Velky L; Greenlee S; Wang MT; Drake TA; Lusis AJ
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2671-6. PubMed ID: 17916774
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
